As expected, copy number gains and gene amplification of the PRL-3 gene occurred in 43% (158/364) and 16% (59/364) of HCC tissues, respectively, in the TCGA-LIHC dataset (Figure 2A). This evidence concerns the gene PTP4A3 and hepatocellular carcinoma.